[
  {
    "ts": null,
    "headline": "If EPS Growth Is Important To You, ResMed (NYSE:RMD) Presents An Opportunity",
    "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
    "url": "https://finnhub.io/api/news?id=0cb876968de119e86dc185a7a64a4cc3f892208ff09b4ec7402fd97f5fc472a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771246815,
      "headline": "If EPS Growth Is Important To You, ResMed (NYSE:RMD) Presents An Opportunity",
      "id": 139114252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
      "url": "https://finnhub.io/api/news?id=0cb876968de119e86dc185a7a64a4cc3f892208ff09b4ec7402fd97f5fc472a4"
    }
  },
  {
    "ts": null,
    "headline": "Invesco International Growth Fund Q4 2025 Portfolio Update",
    "summary": "Invesco International Growth Fund underperformed most in industrials, consumer discretionary and communication services, all due to stock selection. Read more here.",
    "url": "https://finnhub.io/api/news?id=d03b2665083d3cd5355923f3a02f57665fa5106ff978b46fd1c79a6b0e149d0d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771242180,
      "headline": "Invesco International Growth Fund Q4 2025 Portfolio Update",
      "id": 139115220,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2231926077/image_2231926077.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "Invesco International Growth Fund underperformed most in industrials, consumer discretionary and communication services, all due to stock selection. Read more here.",
      "url": "https://finnhub.io/api/news?id=d03b2665083d3cd5355923f3a02f57665fa5106ff978b46fd1c79a6b0e149d0d"
    }
  },
  {
    "ts": null,
    "headline": "ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?",
    "summary": "Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=ee51adbccbc2ab02ce7f642fdb2ce971b0105bb5c2cb80b9169c4c1025c489e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771214587,
      "headline": "ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?",
      "id": 139111794,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=ee51adbccbc2ab02ce7f642fdb2ce971b0105bb5c2cb80b9169c4c1025c489e9"
    }
  }
]